[1]
M. Bibi, “The Role of Neutrophil to Lymphocyte Ratio in Predicting the Response to Neoadjuvant Targeted Therapies in HER2-Positive Breast Cancer: Predictive Value of NLR in HER2-Positive Breast Cancer”, PJHS-Lahore, vol. 7, no. 3, pp. 149–154, Mar. 2026.